ID   SW1736 eGFP-H2B
AC   CVCL_IY89
DR   cancercelllines; CVCL_IY89
DR   Wikidata; Q54971091
RX   PubMed=26958598;
CC   Sequence variation: Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Gln192Ter (c.574C>T); ClinVar=VCV000406579; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 12373; TSHR; Simple; p.Ile486Phe (c.1456A>T); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=Human histone H2B (Note=But which of the H2B genes is not specified).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3883 ! SW1736
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-09-24; Version: 18
//
RX   PubMed=26958598; DOI=10.1016/j.dib.2015.09.030; PMCID=PMC4773363;
RA   Ikeda K., Tachibana T., Suzuki Y., Fujioka K., Takeyama H., Manome Y.;
RT   "Abnormal number cell division of human thyroid anaplastic carcinoma
RT   cell line, SW 1736.";
RL   Data Brief 5:396-398(2015).
//